BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32108379)

  • 21. Gastrointestinal mucosal barrier function and diseases.
    Oshima T; Miwa H
    J Gastroenterol; 2016 Aug; 51(8):768-78. PubMed ID: 27048502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of tight junction barrier integrity in cell turnover and skin diseases.
    Yokouchi M; Kubo A
    Exp Dermatol; 2018 Aug; 27(8):876-883. PubMed ID: 30019465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tight junctions and cell-cell interactions.
    Utech M; Brüwer M; Nusrat A
    Methods Mol Biol; 2006; 341():185-95. PubMed ID: 16799199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outside-in hypothesis revisited: The role of microbial, epithelial, and immune interactions.
    Sugita K; Soyka MB; Wawrzyniak P; Rinaldi AO; Mitamura Y; Akdis M; Akdis CA
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):517-527. PubMed ID: 32454094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the intestinal barrier by nutrients: The role of tight junctions.
    Suzuki T
    Anim Sci J; 2020; 91(1):e13357. PubMed ID: 32219956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals.
    Lee B; Moon KM; Kim CY
    J Immunol Res; 2018; 2018():2645465. PubMed ID: 30648119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently.
    Bergmann S; von Buenau B; Vidal-Y-Sy S; Haftek M; Wladykowski E; Houdek P; Lezius S; Duplan H; Bäsler K; Dähnhardt-Pfeiffer S; Gorzelanny C; Schneider SW; Rodriguez E; Stölzl D; Weidinger S; Brandner JM
    Sci Rep; 2020 Feb; 10(1):2024. PubMed ID: 32029783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of intestinal epithelial permeability by tight junctions.
    Suzuki T
    Cell Mol Life Sci; 2013 Feb; 70(4):631-59. PubMed ID: 22782113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march.
    Egawa G; Kabashima K
    J Allergy Clin Immunol; 2016 Aug; 138(2):350-358.e1. PubMed ID: 27497277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy and tight junction proteins in the intestine and intestinal diseases.
    Hu CA; Hou Y; Yi D; Qiu Y; Wu G; Kong X; Yin Y
    Anim Nutr; 2015 Sep; 1(3):123-127. PubMed ID: 29767173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocytosis of Intestinal Tight Junction Proteins: In Time and Space.
    Nighot P; Ma T
    Inflamm Bowel Dis; 2021 Jan; 27(2):283-290. PubMed ID: 32497180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
    Kuo IH; Carpenter-Mendini A; Yoshida T; McGirt LY; Ivanov AI; Barnes KC; Gallo RL; Borkowski AW; Yamasaki K; Leung DY; Georas SN; De Benedetto A; Beck LA
    J Invest Dermatol; 2013 Apr; 133(4):988-98. PubMed ID: 23223142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological changes in tight junctions and potential applications into therapies.
    Takahashi A; Kondoh M; Suzuki H; Watari A; Yagi K
    Drug Discov Today; 2012 Jul; 17(13-14):727-32. PubMed ID: 22414542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate lymphoid type 2 cells in chronic rhinosinusitis.
    Vreugde S; Wormald PJ
    Curr Opin Allergy Clin Immunol; 2016 Feb; 16(1):7-12. PubMed ID: 26600260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary barrier-related diseases involving the tight junction: lessons from skin and intestine.
    Brandner JM; Schulzke JD
    Cell Tissue Res; 2015 Jun; 360(3):723-48. PubMed ID: 25663273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption.
    Ivanov AI; Nusrat A; Parkos CA
    Novartis Found Symp; 2004; 263():115-24; discussion 124-32, 211-8. PubMed ID: 15669638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function.
    Akiyama T; Niyonsaba F; Kiatsurayanon C; Nguyen TT; Ushio H; Fujimura T; Ueno T; Okumura K; Ogawa H; Ikeda S
    J Innate Immun; 2014; 6(6):739-53. PubMed ID: 24862212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Layered defense: how mucus and tight junctions seal the intestinal barrier.
    Capaldo CT; Powell DN; Kalman D
    J Mol Med (Berl); 2017 Sep; 95(9):927-934. PubMed ID: 28707083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergies Come Clean: The Role of Detergents in Epithelial Barrier Dysfunction.
    Wright BL; Masuda MY; Ortiz DR; Dao A; Civello B; Pyon GC; Schulze AR; Yiannas JA; Rank MA; Kita H; Doyle AD
    Curr Allergy Asthma Rep; 2023 Aug; 23(8):443-451. PubMed ID: 37233851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.